Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2012 / Cilt: 46 - Sayı: 3

Serum TNF-α, IL-6 and resistin levels in chronic plaque psoriasis

Kronik plak tip psoriasiste TNF-α, IL-6 ve resistin seviyeleri

Pages
138–142
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Larger studies are needed to support our findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Psoriasis is a chronic recurrent inflammatory disease of the skin.
📊
Key Findings & Data:Obesity is a significant risk factor for psoriasis and body mass index (BMI) correlates with the disease severity.
💡
Conclusion & Impact:Larger studies are needed to support our findings.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: Psoriasis is a chronic recurrent inflammatory disease of the skin. Despite previous extensive studies, etiology is still unclear. Obesity is a significant risk factor for psoriasis and body mass index (BMI) correlates with the disease severity. In recent years, the relationship between psoriasis and adipose tissue cytokines has been reported. Therefore, in this study, we aimed to determine the levels of adipose tissue cytokines TNF-α, IL-6 and resistin in psoriasis patients and to evaluate their relation with disease severity. Material and Methods: Our study was performed between January 2010 and February 2010 on a total of 40 patients who were admitted to Abant Izzet Baysal University, Medical School Clinic of Dermatology with complaints of psoriasis. Additionally, forty healthy individuals whose age, gender and BMI did not differ from the patients ones formed the control group. TNF-α, IL-6, and resistin levels were measured in both the patients diagnosed with psoriasis and the control group using ELISA methods. The ttest and Mann-Whitney U test were performed to examine the differences between the two groups. Results: In our study, TNF-α, IL-6, and resistin levels were all significantly elevated in the patient group, and serum IL-6 and resistin correlated with disease severity. Psoriasis Area Severity Index (PASI) score showed statistically significant association with IL-6 and resistin levels. Furthermore, it was detected that BMI did not correlate with serum TNF-α, IL-6, and resistin levels. Conclusion: The results of our study showed that TNF-α, IL-6, and resistin play a part in psoriasis etiopathogenesis, and IL-6 and resistin can be used as markers to assess the severity of the disease. Also, our study showed that the elevation in serum TNF-α, IL-6, and resistin levels is independent from the increase in adipose tissue. Larger studies are needed to support our findings.

Özet

Amaç: Psoriasis kronik, tekrarlayıcı, inflamatuvar bir deri hastalığıdır. Etyolojisi ve patogenezi günümüzde tam olarak aydınlatılamamıştır. Obezite psoriasis için önemli bir risk faktörüdür ve vücut kitle indeksi hastalık şiddetiyle korelasyon gösterir. Son yıllarda psoriasisin adipoz doku sitokinleri ile ilişkisi bildirilmiştir. Bu nedenle biz de bu çalışmada psoriasisli hastalarda, adipoz doku sitokinleri olan TNF-α, IL-6 ve resistin gibi adipokinlerin düzeylerini belirlemeyi ve hastalık şiddetiyle ilişkisini değerlendirmeyi amaçladık. Gereç ve Yöntem: Çalışmamız Ocak-Şubat 2010 tarihleri arasında Dermatoloji polikliniğine başvuran 40 psoriasis hastasını kapsamaktadır. Bu hastalar ile birlikte yaş, cinsiyet, vücut kitle indeksi istatistiksel fark oluşturmayan 40 sağlıklı birey de kontrol grubu olarak değerlendirilmiştir. Psoriasis tanısı konulan hastalarda ve kontrol grubunda TNF-α, IL-6 ve resistin seviyeleri ELİSA yöntemi kullanılarak ölçüldü. Gruplar arası farkın değerlendirilmesi t testi ve Mann-Whitney U testi kullanılarak yapıldı. Bulgular: Hasta grubunun serum TNF-α, IL-6, resistin seviyeleri kontrol grubuyla karşılaştırıldığında TNF-α, IL-6 ve resistin seviyeleri hasta grubunda istatistiksel olarak anlamlı derecede yüksek saptandı. Psoriasis alan şiddet indeksi (PAŞİ) skoru ile IL-6, resistin arasında istatistiksel anlamlılık tespit edildi. Hastaların TNF-α, IL-6 ve resistin seviyeleriyle vücut kitle indeksleri arasında istatistiksel anlamlılık olmadığı görüldü. Sonuç: Bulgularımız TNF-α, IL-6 ve resistinin psoriasis etyopatogenezinde rol aldığını, IL-6 ve resistinin hastalık şiddeti ile ilgili belirteçler olabileceğini düşündürmektedir. Ayrıca çalışmamız söz konusu sitokinlerin psorisis hastalarında adipoz doku artışından bağımsız olarak yüksek olduğu görüşünü de desteklemektedir. Bununla birlikte konunun daha geniş çalışmalarla desteklenmesi gerekmektedir.

🔖

Cite This Article

POLAT, M., PARLAK, A. H., YILDIRIM, Y., SERİN, E. (2022). Serum TNF-α, IL-6 and resistin levels in chronic plaque psoriasis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 46 - Sayı: 3, 138–142. https://ajindex.com/articles/621918

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Van de Kerkhof PCM: Psoriasis. Dermatology. Ed. Bolognia JL, Jorizzo JL, Rapini RP. London, Mosby, 2003;125–49
  2. Juge-Aubry CE, Henrichot E, Meier CA: Adipose tissue: a regulator of inflammation, Best Pract Res Clin Endocrinol Metab 2005;19:547-66
  3. Silswal N, Singh A, Aruna B, et al: Human resistin stimulates the proinflammatory cytokines TNF-alpha and IL-12 in macrophages by NF kappa B dependent pathway. Biochem Biophys Res Commun 2005;334:1092-101
  4. Aruna B, Ghosh S, Singh A.K, et al: Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages. Biochemistry 2003;42:10554-59
  5. Filkova M, Haluzik M, Gay S, Senolt L: The role of resistin as a regulator of inflamation: implication for various human pathologies. Clin Immunol 2009;133:157-70
  6. Nickoloff BJ, Xin H, Nestle FO, Qin JZ: The cytokine and chemokine network in psoriasis. Clin Dermatol 2007;25:568-73
  7. JR Bradley: TNF mediated inflammatory disease. J Pathol 2008;214:149-60
  8. Bonifati C, Carducci M, Cordiali-Fei P, et al: Correlated increases of tumor necrosis factor-alpha, interleukin-6 and granulocyte monocyte colony stimulating factor levels in suction blister fluids and sera of psoriatic patients: relationships with disease severity. Clin Exp Dermatol 1994;19:383-87
  9. Johnston A, Arnadottir S, Gudjonsson JE, et al: Obesity in psoriasis: leptin and resistin as mediators of cutaneus inflammation. Br J Dermatol 2008;159:342-50
  10. Berköz M, Yalın S: Immunologic and inflammatory functions of adipose tissue. Mersin Univ Saglık Bilim Derg 2008;1:1-9
  11. Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFNgamma, IL-6, IL-8, IL-12, IL-17 and IL-18 in ptients with active psoriasis and correlation with disease severity. Mediators In flamm 2005;2005:273-79
  12. Mussi A, Bonifati C, Carducci M, et al: Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents 1997;11:115-8
  13. Abanmi A, Al Harthi F, Al Agla R, et al: Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia. Int J Dermatol 2005;44:82–3
  14. Gönül T, Başak PY, Kara Y, et al: Psoriasisli hastalarda serum leptin düzeylerinin araştırılması. Turkderm 2009;43:48-52
  15. Chodorowska G: Plasma concentrations of IFN- gama and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment. J Eur Acad Dermatol Venerol 1998;10:14